Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial.
about
Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgeryAntithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgeryComparative Efficacy and Safety of Different Antiplatelet Agents for Prevention of Major Cardiovascular Events and Leg Amputations in Patients with Peripheral Arterial Disease: A Systematic Review and Network Meta-AnalysisCritical limb ischemia: advanced medical therapyEffect of addition of clopidogrel to aspirin on mortality: systematic review of randomized trialsComparative effectiveness review of antiplatelet agents in peripheral artery diseaseEfficacy and safety of adding clopidogrel to aspirin on stroke prevention among high vascular risk patients: a meta-analysis of randomized controlled trials.Efficacy of two different self-expanding nitinol stents for atherosclerotic femoropopliteal arterial disease (SENS-FP trial): study protocol for a randomized controlled trial.Systematic reviews and meta-analyses for more profitable strategies in peripheral artery diseaseComparison of graft patency, limb salvage, and antithrombotic therapy between prosthetic and autogenous below-knee bypass for critical limb ischemiaVA Vascular Injury Study (VAVIS): VA-DoD extremity injury outcomes collaboration.Antiplatelet therapy for peripheral arterial disease and critical limb ischemia: guidelines abound, but where are the data?Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis.Antithrombotic therapy in peripheral artery disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Impact of antiplatelet treatment on colorectal cancer staging characteristics.A review of the role of anticoagulation in the treatment of peripheral arterial disease.Management of Critical Limb Ischemia.Clopidogrel is not associated with major bleeding complications during peripheral arterial surgeryPeripheral artery disease. Part 2: medical and endovascular treatment.Preventive aspects in peripheral artery disease.Perioperative management of peripheral vascular trauma.Role and management of coagulation disorders in peripheral arterial disease.Surveillance after distal revascularization for critical limb ischaemia.Medical management of critical limb ischaemia: where do we stand today?Distal bypasses in patients with diabetes and infrapopliteal disease: technical considerations to achieve success.Peripheral interventions and antiplatelet therapy: Role in current practice.Current therapies and investigational drugs for peripheral arterial disease.Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: conceptual evolution based on emerging evidence.Antithrombotic therapy in peripheral artery disease.Antithrombotic Therapy After Peripheral Vascular Intervention.Medical Therapy in Peripheral Artery Disease and Critical Limb Ischemia.Vein graft failure: from pathophysiology to clinical outcomes.Comparative effectiveness of anticoagulation on midterm infrainguinal bypass graft patency.2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Perioperative clopidogrel is associated with increased bleeding and blood transfusion at the time of lower extremity bypass.SAFE (Sarpogrelate Anplone in Femoro-popliteal artery intervention Efficacy) study: study protocol for a randomized controlled trial.In vivo study of a model tissue-engineered small-diameter vascular bypass graft.Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events.[ESC guidelines 2017 on peripheral arterial diseases : Summary of the most important recommendations and innovations].
P2860
Q24188060-A2B001C4-B3B5-4666-8D76-1C422DD63990Q24236309-46607603-5BF2-472D-9B6F-F81AB74C305CQ26798134-1877F979-51EC-4842-98CB-ADC2B56BDBB5Q26995245-57C94EE3-FD56-462E-86B6-36EDDC2ADCDDQ26999848-6F333CF7-738D-4557-85A6-404EF7ADC3F8Q27023150-CBFD2565-4879-40B6-8433-5FB0E9F6A1D7Q34028223-8B24EB9F-CC24-4181-8AD5-5C03A24D788DQ34227383-BE6D7437-387D-4991-8A69-FD6A6CC9A1A4Q34576281-5D838B97-DCD5-4D8C-A6A0-FF8C6AAA453AQ34786122-878C1002-E0BF-4876-B75F-17AAEB37CF7CQ35083475-03BAA5EC-4938-4316-BC59-3B59583FD7F6Q35216396-28C90534-5076-436F-BCAC-F7C8CB7A3A11Q35283386-AF826DA8-A330-465A-93B3-03B10878934FQ35752591-409DAA31-38B4-4B4D-B148-EE85DE4C7038Q36365830-51FC1E43-6CC3-47E3-A39F-A0F12C13270BQ36627535-47A493B5-9F98-4F9A-AC20-09A615D2EF93Q36786241-A7CBE79F-93D8-4F61-AFD0-0B6FBF351D6CQ37625068-E6A223B5-49CD-4E5F-A68E-B91AF5920057Q37889106-19D3A9D8-0C51-4453-AB75-0600CD4DDF63Q37984281-556E7393-5DA8-4FD1-AA5E-C2F991B25D18Q38006459-11392FA4-9481-4D4C-AE24-ADB5D2CED8E0Q38012698-D266FC49-52B2-4ECC-AE7C-317B23C41973Q38012703-D26CFEEA-1AAC-4B5C-A14B-34593039A6DDQ38116561-B37409B2-3735-443F-8A14-5425B5AC8ED4Q38239875-5E27DA02-0AC5-40AE-8DD7-610D6F12D3DEQ38616610-F4A997AC-C47F-41BC-BDE0-934EA33E3AEBQ38657444-3FFE4461-B053-4E0B-BC7A-F3BEDF329D19Q38706266-BB3F82D1-BB5E-4F71-B2EF-BB7091606C2CQ38715643-BA539E40-8D0F-425A-A951-00870602859FQ38721851-D8522344-D336-41D5-926E-2950426812EEQ38834990-8EE02104-456A-45A1-8884-5160AD2FE32BQ38837879-E727908B-DE3E-43A0-9DE3-6A690ACB793EQ38841676-49A1BA4A-7CD5-4C51-A927-6192F5284F4EQ39007230-6FD2C49B-A84B-4F44-BEF9-EED7CFB224E0Q39007236-ED9DAE5A-B486-4A93-A413-8C2079DC0B5AQ40323370-28AFA526-72BE-435E-9450-E36086AA9707Q41955689-B1ED8E2C-523E-4E0C-95B3-DEEFCE0C5472Q44337285-2E3FBD7D-D97E-49F4-BF9D-40CBC3C6FB91Q47309879-A64E76A9-2AB0-47F6-9E44-13CED0846EAAQ49977922-CD2A5626-5109-4BF8-B1AB-0C7214494FB8
P2860
Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Results of the randomized, pla ...... terial disease (CASPAR) trial.
@en
Results of the randomized, pla ...... terial disease (CASPAR) trial.
@nl
type
label
Results of the randomized, pla ...... terial disease (CASPAR) trial.
@en
Results of the randomized, pla ...... terial disease (CASPAR) trial.
@nl
prefLabel
Results of the randomized, pla ...... terial disease (CASPAR) trial.
@en
Results of the randomized, pla ...... terial disease (CASPAR) trial.
@nl
P2093
P1476
Results of the randomized, pla ...... rterial disease (CASPAR) trial
@en
P2093
A Leizorovicz
B Eikelboom
CASPAR Writing Committee
D Bergqvist
F Vermassen
P304
825-33, 833.e1-2
P356
10.1016/J.JVS.2010.04.027
P577
2010-08-01T00:00:00Z